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Abstract
The withdrawal of artiﬁcial nutrition and hydration or other life-sustaining treatments is a clinical
decision, made in ICUs or in other settings, involving patients suffering from serious and irreversible
diseases or impaired consciousness. Such clinical decisions must be made in the best interests of the
patient, and must respect the wishes previously expressed by patients, laid down in their wills, in
advance directives or in information passed on by relatives or legally appointed health-care agents,
and in observance of common bioethical and legal rules in individual nations. Intensivists who are
expert in the management of life-sustaining treatments are also involved in deciding when to
withdraw futile therapies and instigate end-of-life care procedures for dying patients, with the sole
aim of providing comfort and ensuring that suffering is not prolonged unnecessarily.
List of Abbreviations
ICU Intensive care unit
Introduction
End-of-life care procedures, including the withdrawal of artiﬁcial nutrition and hydration, demand
from staff the same level of technical competence required in providing life-sustaining treatments
but may appear to be more controversial because of the very nature of the intensive care setting and
the speciﬁc skills possessed by and the demands made of the physicians working in ICUs
(Rubenfeld 2004; Siegel 2009; Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen and
Lanken 2000).
The main aim of intensive care medicine is to treat acute life-threatening diseases in order to
assure a positive outcome, with the patient’s survival and eventual discharge.
While physicians and nurses working in ICUs have extensive knowledge, experience, and
technical skills which are mainly directed toward providing life-sustaining treatments, ensuring
survival, and restoring the quality of patients’ lives, they may sometimes not consider terminal care
procedures to be as relevant as other activities performed in the intensive care setting (Rubenfeld
2004; Siegel 2009; Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen and Lanken 2000).
The admission of a patient to an ICU represents, above all, a therapeutic challenge to the clinical
team, but when all treatments fail, the physicians and the nursing staff, as well as patients and their
families, have to consider the transition from curative to palliative care (Rubenfeld 2004; Siegel
2009; Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen and Lanken 2000).
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It may, for a variety of reasons, sometimes be difﬁcult to make a decision involving the
withdrawal of life-sustaining support from a terminally ill patient admitted to an ICU due to an
impaired neurological state, sedative or opioid therapy, or tracheal intubation, because:
(a) The patient, if an adult, has not left an advance directive.
(b) There is a lack of information regarding his or her values and wishes.
(c) There are no parents, relatives, or health-care agents.
Physicians are clearly not obliged to continue unsuccessful or futile treatments and are certainly
concerned that ethical and legal principles should be upheld while also acting in the patient’s best
interests (Rubenfeld 2004; Siegel 2009; Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen
and Lanken 2000).
On the other hand, the switch from providing life-sustaining treatment for a patient to preparing
for his or her death, which normally means providing comfort and palliative treatments, whether in
an ICU or in other clinical settings, requires intensivists to recognize that:
(a) Withdrawing life support in cases of serious and irreversible diseases or impaired consciousness
may be considered to be in the best interests and wishes of the patients while also preventing
futile treatments and prolonged suffering.
(b) Withholding and withdrawing life support, if respectful of bioethical and legal rules, are
equivalent medical approaches.
(c) Withdrawing life support means that the patient is allowed to die, which is most deﬁnitely not the
same as euthanasia.
(d) Administering drugs in order to make the patient comfortable (even though this will, in all
probability, hasten the patient’s death) does not imply an intention to cause the patient’s death.
(e) The withdrawal of life support may be a common occurrence, but the denial of special care, such
as comfort-giving and palliative treatments, should under no circumstances occur.
(f) Withdrawing life support has to be regarded as one of many critical care procedures to be used
during the dying phase and included in the experience and technical training of physicians and
other professionals working in ICUs (Rubenfeld 2004; Siegel 2009; Truog et al. 2008; Puntillo
et al. 2014; Faber-Langendoen and Lanken 2000) (Table 1).
Once the transition from treatment to comfort and palliative care has been made, those interven-
tions which do not contribute to the patient’s comfort will be suspended. These may include the
Table 1 Principles of withdrawing life support in adult patients in ICUs
Withdrawing life support in cases of serious and irreversible diseases or impaired consciousness is planned in the best
interests and wishes of the patients and to prevent futile treatments and prolonged suffering
Withholding and withdrawing life support are equivalent medical approaches when applied in the respect of bioethical
and legal rules
Withdrawing life support means that the patient is allowed to die; this is not conceptually the same as euthanasia
While hastening the patient’s death, the prescription of drugs in order to make the patient comfortable does not imply the
intention to cause the patient’s death
The denial of special care, such as comfort-giving and palliative treatments, should under no circumstances occur when
withdrawing life support is started
Withdrawing life support should be regarded as one of many critical care procedures to be used during the dying phase
and included in the experience and technical training of physicians and other professionals working in ICUs
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cessation of artiﬁcial nutrition and hydration and the suspension of the use of vasoactive drugs,
antibiotics, blood products, or other treatments. It may also involve the withdrawal of invasive
cardiorespiratory monitoring, mechanical ventilation, noninvasive mechanical ventilation, mechan-
ical cardiocirculatory support, renal dialysis, etc. and the writing of a do-not-resuscitate order. Drugs
such as opioids and benzodiazepines or other sedatives which control the discomfort caused by pain,
dyspnea, and respiratory stress will be prescribed and titrated as for any other pharmacological
intervention in critical care practice (Rubenfeld 2004; Siegel 2009; Truog et al. 2008; Puntillo
et al. 2014; Faber-Langendoen and Lanken 2000).
Medical records will include all data concerning terminal clinical conditions and document the
clinical steps and decisions arising from meetings with the adult patient and surrogates leading up to
the decision to withdraw life support. These notes will also document plans for withdrawal therapies
and resuscitation, the drugs used for sedation and analgesia, and the do-not resuscitate orders
(Rubenfeld 2004; Siegel 2009; Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen and
Lanken 2000).
Lastly, the responsibility of physicians and nurses toward the patient does not end when the
decision to withdraw life-sustaining treatment is taken but continues right through the dying process.
This demands the same level of care and skill shown when patients are admitted to ICUs and must
therefore be considered as a normal medical procedure and of no less importance (Rubenfeld 2004;
Siegel 2009; Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen and Lanken 2000).
The management of the dying process of a critically ill patient has nowadays to be regarded as a
key professional skill for physicians involved in end-of-life care (Rubenfeld 2004; Siegel 2009;
Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen and Lanken 2000).
Applications to Intensive Care: Bioethical and Medicolegal Implications
The withdrawal of artiﬁcial nutrition and ﬂuid support as well as other life-sustaining therapies is
sometimes practiced in Europe and North America with patients suffering from benign or malignant
diseases, where the prognosis is severe and irreversible, or in cases of impaired consciousness
(coma, permanent vegetative state, brain death). This process may involve patients admitted to
medical or surgical wards or to ICU departments.
Decisions to withdraw artiﬁcial sustenance and other life-sustaining supports bring physicians
and intensivists face to face with their ethical responsibilities, the speciﬁc laws of individual
countries, and the potential conﬂict between them. In those cases where no advance directives
exist, where it is impossible to know the wishes of the incompetent patient and where the physicians
and family fail to reach agreement, the courts will be asked to intervene.
Legal codes generally acknowledge that physicians do not have to provide treatment which they
consider to be futile or against the patient’s interests, while recognizing the rights of each patient to
receive care based on certain standards of competence and behavior, below which a physician may
be guilty of negligence or perhaps even criminally responsible (Korner et al. 2006).
All doctors should know if and when treatment is futile or excessively aggressive and should
promote the concepts of palliative support, symptom relief, and preservation of dignity (Korner
et al. 2006).
The basic ethical duties in medical practice are beneﬁcence (the duty to promote good and act in
the best interests of the patient and his health), nonmaleﬁcence (the duty not to harm the patient),
respect for the patient’s autonomy, dignity and choices, together with the concepts of truth-telling
and informed consent (Snyder 2012).
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Although the laws in different countries and the ways in which they are applied are evolving to
keep pace with the development of new medical-ethical values, physicians must always remember
that, as law-abiding citizens and members of a profession, they are bound to respect and apply the
laws of their country when taking a decision to withdraw life-sustaining treatment (Snyder 2012).
These interactions between medical ethics and the law are even more problematic in those cases
where adult patients have lost their decision-making capacity. As a result, in many countries laws
exist which allow people, while still in possession of their faculties, to prepare a written statement of
their end-of-life preferences and choose a surrogate to act on their behalf should they be unable to
express their own health-care decisions.
Competent adult patients should be told by physicians about the severity of their clinical
conditions and their prognosis and must be able to:
(a) Understand what the proposed treatments consist of and why they are being proposed or why
alternatives are being rejected.
(b) Understand the potential beneﬁts, risks and complications, the possibility of failure, the exis-
tence of alternative treatments, and the futility of certain treatments.
(c) Understand the consequences of refusing the proposed treatments and be able to retain the
information given to them so that they can reﬂect and make a pondered decision or indeed
change their decision at a later stage.
(d) Make decisions freely without being subjected to any kind of psychological pressure (Korner
et al. 2006; Snyder 2012) (Table 2).
When an adult patient is prey to a serious, incurable, and terminal condition and is no longer
competent, all his or her prior oral or written statements concerning the maintenance, rejection, or
interruption of life-sustaining treatment will be taken into account by physicians (Korner et al. 2006;
Snyder 2012) (Table 3).
This principle is implicit in article 9 of the Convention on Human Rights and Biomedicine,
approved by the European Council in Oviedo in 1997. It states that “The previously expressed
Table 2 Competent adult patients preparing a written statement on end-of-life preferences or choosing a surrogate must
be able to
Understand what the proposed treatments consist of, why they are being proposed, and why the alternatives are being
rejected
Understand the potential beneﬁts, risks and complications, possibility of failure, existence of alternative treatments, and
futility of certain treatments
Understand the consequences of refusing the proposed treatments, retain the information given, reﬂect and make a
pondered decision, or indeed change any decision at a later stage
Make decisions freely and without any kind of psychological pressure
Table 3 In cases of patients who are no longer competent, family and physicians should take into account
All prior oral or written statements concerning the maintenance, rejection, or interruption of life-sustaining treatments
The ascertainment of the adult patient’s presumed wishes on the basis of information gleaned from parents, relatives,
friends, or witnesses in cases where there is no written statement
That a ﬁnal decision on withdrawing artiﬁcial nutrition and hydration will have to be delivered by a court
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wishes relating to a medical intervention by an adult patient who is not, at the time of intervention, in
a state to express his or her wishes, shall be taken into account.”
Speciﬁc preferences for care involve the refusal or acceptance of any medical, surgical, or
resuscitative treatment, including the use of artiﬁcial sustenance and life-sustaining procedures,
and the right to be given all relevant information about the diagnosis and prognosis of the illness
(Korner et al. 2006; Snyder 2012).
All the speciﬁc wishes of an adult patient should be included in an ofﬁcial, legally recognized
document, known as an advance directive, which contains written preferences concerning their
end-of-life treatment in the event that he or she is no longer able to make decisions due to illness or
incapacity (Korner et al. 2006; Snyder 2012).
Family, physicians, and the courts will evaluate this information if adult patients are unable to
make their own health-care decisions or to express themselves because they are in a coma or a
vegetative state or are afﬂicted by other irreversible diseases or unexpected end-of-life situations
(Korner et al. 2006; Snyder 2012).
Advance directives generally include the following:
(a) A living will, which is a list of all medical procedures and life-sustaining measures the person
agrees to or rejects, including mechanical ventilation, renal dialysis, artiﬁcial nutrition, and
hydration via feeding tubes or intravenous catheters, and whether they wish to donate their
organs or not.
(b) A medical or personal welfare power of attorney, which nominates a health-care agent who is
authorized to take medical decisions should the signatory become incompetent. The health-care
agent so designated will act on the adult patient’s behalf and interpret his or her wishes even in
situations not directly covered in the text of the living will. The designated agent may also act on
behalf of the incapacitated person when his or her family opposes the patient’s wishes as
described in the living will.
(c) A do-not-resuscitate order which prohibits cardiopulmonary resuscitation should the patient
experience cardiorespiratory arrest (Table 4).
When physicians consider that a patient’s advance directives are not acceptable or applicable, it
will become necessary to refer to hospital protocols or its ethics committee or to the laws of the
country in question (Korner et al. 2006; Snyder 2012).
A person suffering from an irreversible or terminal illness frequently has no decision-making
capability, has not drawn up an advance directive, or did not nominate a health-care agent (Korner
et al. 2006; Snyder 2012).
Table 4 Essentially the official, legally recognized document known as an advance directive include
Any written preferences concerning the end-of-life treatment should the patient no longer be able to make decisions due
to illness or incapacity
The living will, which is the list of all medical procedures and life-sustaining measures the person agrees to or rejects,
including mechanical ventilation, renal dialysis, artiﬁcial nutrition, and hydration via feeding tubes or intravenous
catheters, and the wish to donate organs or not
The medical or personal welfare power of attorney, which nominates a health-care agent who is authorized to take
medical decisions should the signatory become incompetent
The do not resuscitate order which prohibits cardiopulmonary resuscitation should the patient experience
cardiorespiratory arrest
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In this case every decision regarding the choice of withholding or withdrawing treatment must be
taken in the patient’s best interests, and respect their presumed wishes on the basis of information
gleaned from parents, relatives, friends, or witnesses. Obviously, in the absence of any clear
instructions, staff should attempt to understand what the adult patient would have chosen by learning
about his or her moral values and opinions concerning end-of-life care (Korner et al. 2006; Snyder
2012).
These discussions should be held with the family, the hospital staff and ethics committee, and, if
necessary, the courts (Korner et al. 2006; Snyder 2012).
In cases where an incompetent adult patient has no family, friends, or agent, it may be necessary to
resort to the courts for a decision on withholding or withdrawing medical support and artiﬁcial
sustenance (Korner et al. 2006; Snyder 2012).
The withholding and withdrawal of life-sustaining treatments should be regarded as of equal
medical and technical validity, with both being in accordance with the patient’s dignity and freedom
to decide, so long as they are carried out in conformity with a country’s ethical codes and legislation,
with the patient’s advance directives (be they documented or surmised) and in his/her best interests
(American Medical Association 2006; British Medical Association 1999; American Academy of
Neurology 1989; Snyder 2012).
Where treatment, including artiﬁcial nutrition and hydration, proves to be of no beneﬁt to the
patient, is excessively painful or detrimental, or results in unbearable psychological suffering, it can
be halted if so requested by a competent adult patient or surrogate or as a consequence of a decision
taken by the medical team when there is clearly no moral or legal obligation to provide or continue a
treatment that is not in the patient’s best interests (Jennett 2002; American Medical Association
2006; British Medical Association 1999; American Academy of Neurology 1989; Snyder 2012).
This means that in many countries, doctors may not legally end life but are not ethically and
legally required to prolong the process of dying. The idea of prolonging life is a worthy medical
objective, but therapeutic obstinacy may harm patients and rob them of their dignity (Korner
et al. 2006).
Nowadays, in many European countries and in the North America, both in common and civil law
systems, the principle of self-determination is considered a fundamental constitutional right, which
allows every informed citizen to accept or refuse medical treatment.
Legal systems and the courts generally approach every decision involving the withholding or
withdrawal of artiﬁcial nutrition and hydration or other life-sustaining procedures by observing the
following steps in adult patients:
(a) The patient’s advance care plans must be written when he or she still retains full decision-making
capacity.
(b) The patient’s real desires must be ascertained, in the form of a written proﬁle of his or her
personality and moral principles, prepared by the health-care agent, parents, relatives, friends, or
witnesses.
(c) The utility or futility of medical treatments and life-sustaining interventions must be evaluated
with the patient’s best interests in mind.
(d) Diagnosis of the disease, the severity of the patient’s clinical conditions, and the chances of
reversibility of the illness must be established.
(e) The patient’s prognosis must be determined.
(f) The treatments which might be suspended must clearly be recognized as genuine medical
treatments (at the present time artiﬁcial nutrition and hydration are internationally regarded as
medical treatments and can therefore be refused by the patient).
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(g) The patient’s advance refusal of speciﬁc medical treatments, such as artiﬁcial nutrition and
hydration, must be proven.
(h) Exactly what the physicians will and will not do, once ofﬁcial authorization to proceed has been
given, must be documented (American Medical Association 2006; British Medical Association
1999; American Academy of Neurology 1989; Snyder 2012) (Table 5).
The withdrawal of artiﬁcial nutrition and hydration or other life-sustaining support in a pediatric
context is more controversial than with adults because children or neonates are not able autono-
mously to make advance decisions concerning the acceptance or rejection of medical treatments.
Moreover, the withdrawal of artiﬁcial nutrition and hydration usually has a signiﬁcant emotional
impact on parents and health-care professionals because our knowledge of the level of perceived
discomfort in the infant is incomplete. It is also true that nutrition and hydration, especially in
children and babies, are regarded as a fundamental right and physiological need rather than as
medical treatment (Ellershaw et al. 1995; Winter 2000; Diekema and Botkin 2009; Tsai 2011).
Although these controversies cannot always be resolved, the withdrawal of artiﬁcial nutrition and
hydration in terminally ill children, as in adults, is ethically and clinically acceptable in certain
circumstances.
Diekema and Botkin consider that the withdrawal of nutritional and ﬂuid support can be clinically
permissible when there is consensus that it is not producing a net beneﬁt for the child (Diekema and
Botkin 2009).
Speciﬁcally the following principles must be respected:
(a) Children capable of eating and drinking and showing signs of wanting to eat or drink must be
given food and ﬂuid support.
(b) The products used for artiﬁcial nutrition and hydration amount to medical interventions which
may be withheld or withdrawn just like other medical treatments.
(c) Decisions to withhold artiﬁcial nutrition and hydration should be of overall beneﬁt to the child,
and such treatments may be withdrawn when they serve merely to prolong the dying process
while producing limited or no net beneﬁt. The decision to withhold or withdraw artiﬁcial
nutrition and hydration should always be made in the child’s best interests.
(d) The child deprived of artiﬁcial nutrition and hydration should be kept as comfortable as possible
with comprehensive palliative care, including appropriate analgesia, sedation, oral hygiene, and
humidiﬁcation (Diekema and Botkin 2009; Tsai 2011).
Table 5 Legal systems and the courts approach decisions involving the withholding or withdrawal of artificial nutrition
and hydration or other life-sustaining procedures by observing
The patient’s advance care plans written while still possessing full decision-making capacity
The patient’s real desires, in the form of a written proﬁle of his or her personality and moral principles, prepared by the
health-care agent, parents, relatives, friends, or witnesses
The utility or futility of medical treatments and life-sustaining interventions evaluated with the patient’s best interests in
mind
The diagnosis of the disease, the severity of the patient’s clinical conditions, and the chances of reversibility of the illness
The patient’s prognosis
The treatments which might be suspended (at the present time artiﬁcial nutrition and hydration are internationally
regarded as medical treatments and can therefore be refused by the adult patient)
The patient’s advance refusal of speciﬁc medical treatments, such as artiﬁcial nutrition and hydration
What the physicians will and will not do, once ofﬁcial authorization to proceed has been given
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Despite public and scientiﬁc disputes past and present, artiﬁcial nutrition and hydration are now
generally considered to be medical interventions and therefore subject to the same principles of
patient acceptance or refusal as other medical treatments (e.g., drug therapies, mechanical ventila-
tion, cardiocirculatory support, dialysis, etc.) (American Medical Association 2006; British Medical
Association 1999; American Academy of Neurology 1989; Snyder 2012).
There are several clinical and technical reasons for claiming that artiﬁcial nutrition and hydration
constitutes a medical treatment. Firstly, the administration of ﬂuids and nutrition necessitates the use
of medical equipment and is not a simple nursing procedure. Secondly, the procedure also demands
accurate medical diagnostic and prognostic judgments and an objective evaluation of the advantages
and disadvantages of its application. Thirdly, the patient undergoing artiﬁcial nutrition and hydration
requires careful and continuous surveillance in order to prevent a range of dysmetabolic, infective,
or technical complications (problems involving catheters, pumps, the positioning of tubes, or the
insertion of catheters are all clinically well documented). Fourthly, the manufacture of products for
artiﬁcial nutrition and hydration is the result of complex, standardized pharmaceutical procedures.
Lastly, as with any medical treatments, artiﬁcial nutrition and hydration may fail to provide any real
beneﬁt to the patient or offer any hope of recovery, which means that there can be no ethical or
medical obligation to continue providing it. In short, artiﬁcial nutrition and hydration which do not
provide beneﬁt to the patient and only prolong the dying process, without offering any hope of cure,
can be stopped when it is clear that the patient would not want to receive any further medical
treatment and when the family is in agreement (American Medical Association 2006; British
Medical Association 1999; American Academy of Neurology 1989; Snyder 2012).
Given the continuous evolution of ethical principles and the promulgation of new legal directives
involving end-of-life plans, which are currently being debated in many parts of the world, the level
of perceived discomfort and the speciﬁc ﬁnal causes of death following the withdrawal of artiﬁcial
nutrition and hydration continue to generate considerable pathophysiological, clinical, and medico-
legal interest (Buiting et al. 2007; Bonito et al. 2002; Perry et al. 2005; Breitbart 2005; Solarino
et al. 2011; Moratti 2010; Pasman et al. 2005; McCann et al. 1994; Moreschi et al. 2013).
The cessation of artiﬁcial sustenance and life-sustaining care in cases of permanent vegetative
state continues to be hotly debated. The debate focuses chieﬂy on the possibility that the patient
might recover and on the patient’s hypothetical ability to perceive and process externally some
signals from the surrounding environment (American Academy of Neurology 1989; Bonito
et al. 2002; Jennett 2002; Wade and Johnston 1999).
The withdrawal of artiﬁcial nutrition and hydration and life-sustaining support from patients in
permanent vegetative states may be controversial for some physicians who claim that (1) there exists
a chance, albeit remote, that there might be improvement in patients in states of impaired conscious-
ness and (2) the patient may be capable of minimal conscious processing of signals perceived from
the external environment. In any case, there is no clinical or instrumental data which enable us to
predict the likelihood of neurological improvement in a patient in a state of impaired consciousness.
At present no advanced neurophysiological investigations have been conducted which could help us
to predict a favorable outcome or which demonstrate a minimal ability to process external signals
when in a permanent vegetative state (Rosanova et al. 2012; Lehembre et al. 2012; Katz et al. 2009).
Two emblematic cases were those involving Terri Schiavo in the USA in March 2005 and Eluana
Englaro in Italy in February 2009.
Terri Schiavo had experienced acute cardiac failure and ventricular ﬁbrillation in 1990 due to an
extremely low blood potassium level caused by an eating disorder and dieting. The cardiorespiratory
failure caused a global anoxic-ischemic encephalopathy, typically characterized by diffuse brain
edema and diffuse laminar cortical necrosis, resulting in multifocal cerebral atrophy, diffuse
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ventriculomegaly, and a permanent vegetative state. Fourteen days after the courts had authorized
the withdrawal of artiﬁcial nutrition and hydration, she died of marked dehydration as a direct result
of the electrolyte, and hypovolemic disturbances brought about the lack of hydration (Bonito
et al. 2002; Perry et al. 2005; Breitbart 2005).
Eluana Englaro suffered neurological lesions as the result of a motor vehicle accident which
caused severe brain trauma (diffuse brain edema and bilateral hemorrhagic contusions in the frontal
and temporal regions, basal ganglia, thalamus, mesencephalon, cerebellum, medulla oblongata) and
upper cervical cord trauma (edema and hemorrhagic contusions in the anterior, lateral, and posterior
columns) which resulted in diffuse multifocal brain and upper spinal cord atrophy with
hemosiderinic pigmentation and a consequent permanent vegetative state and quadriplegia. The
courts authorized the withdrawal of artiﬁcial nutrition and hydration, and 87 h later she died of
cardiorespiratory and renal failure compatible with serious dehydration. This induced lethal hyper-
thermia and cardiovascular collapse in a quadriplegic patient who had chronic impairment of
thermal and hemodynamic modulation due to the autonomic denervation resulting from the previous
spinal cord trauma (Solarino et al. 2011; Moratti 2010; Moreschi et al. 2013).
Forensic pathologists who examined the corpses and the clinical records in the two different cases
of Terri Schiavo and Eluana Englaro were asked by the courts to ascertain the following:
– Establish the cause of death.
– Ensure that lethal drugs had not been administered after the court’s decision.
– Verify the correct application of supportive care during the end-of-life phase.
– Ascertain perceived discomfort during the withdrawal of artiﬁcial nutrition and hydration and the
terminal pathophysiological steps in the period immediately prior to death (Bonito et al. 2002;
Perry et al. 2005; Breitbart 2005; Moreschi et al. 2013).
In both the Terri Schiavo and Eluana Englaro cases, the coroners found no signiﬁcant signs of
perceived discomfort due to starvation, which is in accordance with the data published by other
authors who studied discomfort levels during the end-of-life phase in patients whose artiﬁcial
nutrition and hydration have been withdrawn (Bonito et al. 2002; Perry et al. 2005; Breitbart
2005; Moreschi et al. 2013).
There is no published scientiﬁc evidence which conﬁrms that the withdrawal of artiﬁcial nutrition
and hydration induces discomfort or extra suffering in patients in the ﬁnal phase of their lives
(McCann et al. 1994; Moreschi et al. 2013).
Pasman et al. reported that terminally ill patients who are barely or no longer eating or drinking
and those from whom artiﬁcial nutrition and hydration had been withdrawn display no signiﬁcant
differences in the perception of discomfort (Pasman et al. 2005; Moreschi et al. 2013).
McCann et al. reported that feelings of hunger, thirst, dyspnea, agitation, anxiety, and pain in
terminal oncological patients were only slightly lessened during the administration of food and
ﬂuids requested by the patient (McCann et al. 1994; Moreschi et al. 2013).
Furthermore the administration of drugs such as opioids or sedatives, prescribed to alleviate pain,
as well as the humidiﬁcation of mouth mucosal districts, proved to be clinically sufﬁcient to control
discomfort in patients who are experiencing the initial signs of hunger and thirst (Pasman et al. 2005;
McCann et al. 1994; Moreschi et al. 2013).
After the cessation of artiﬁcial nutrition and hydration and before death due to cardiovascular
decompensation, patients perceive little or no discomfort. Systemic decompensation occurs slowly
because it is associated with the activation of speciﬁc biochemical pathways and occurs very slowly
(Pasman et al. 2005; McCann et al. 1994; Moreschi et al. 2013).
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Kerndt et al. reported that the ﬁrst 24 h after the onset of fasting are normally sustained by
glycogenolysis, while during the following eight or more days, gluconeogenesis, protein catabolism,
and the oxidation of fatty acids and ketosis ensure the patient’s survival. The support provided by
these biochemical pathways alleviates the perception of discomfort and delays the inevitable onset
of death by several days (Kerndt et al. 1982; Karlawish et al. 1999; Faber-Langendoen and Lanken
2000; Qaseem et al. 2008; Barr et al. 2013; Moreschi et al. 2013).
Various authors report that in fasting subjects, the burning of fat is the last biochemical pathway in
operation before death and is capable of sustaining the peripheral tissues and central nervous system
(Pasman et al. 2005; McCann et al. 1994; Moreschi et al. 2013).
The onset of death is consequently gradual, taking several days from the initial appearance of
anuria, and this is due to the production of energy and endogenous water which are available from fat
combustion through the oxidation of fatty acids and ketosis and are able to sustain the body’s
demand for energy and water and mitigate any perception of discomfort (Pasman et al. 2005;
McCann et al. 1994; Moreschi et al. 2013).
In the cases of both Terri Schiavo and Eluana Englaro, death was due to terminal cardiovascular
collapse, induced by dehydration. The coroners established that this happened slowly in the demise
of Terry Schiavo (terminal dehydration with electrolyte disturbances brought about by the lack of
hydration) and rapidly in the case of Eluana Englaro (terminal cardiovascular and renal failure with
hyperthermia brought on by the lack of hydration in a quadriplegic subject with basic thermal and
hemodynamic dysregulation).
The real cause of death following the withdrawal of artiﬁcial nutrition and hydration is not the
fasting and starvation per se but two speciﬁc disturbances which have serious pathophysiological
effects on hemodynamic status and thermal regulation:
1. Dehydration and the consequent volemic depletion cause various cardiovascular effects.
Hemodynamic perturbation occurs with the reduction in left ventricular ﬁlling and stroke
volume associated with a compensatory tachycardia with a consequently reduced ability to
perfuse peripheral tissues (Dill and Costill 1974; Nadel 1981; Strydom and Holdsworth 1983).
The human body cannot compensate for acute and persistent volemic depletion due to
dehydration and may suffer from dangerous progressive hemodynamic decompensation.
In the absence of adequate hydration, the subject is unable to compensate for the hypovolemic
condition induced by dehydration, and this leads to progressive fatal cardiovascular decompen-
sation (Dill and Costill 1974; Nadel 1981; Strydom and Holdsworth 1983).
2. Body temperature is normally regulated by the balance between heat production and heat
dissipation. An increase in body temperature occurs when heat production exceeds heat dissipa-
tion, when dissipation is impaired, or when there is excessive ambient heat.
Heat produced by the metabolism, or superﬁcially absorbed when ambient temperatures
exceed body temperature, is mainly dissipated at the skin’s surface. Thermal dissipation via the
skin occurs through convection during peripheral skin vasodilatation and evaporation during
sweating (Strydom and Holdsworth 1983; Harvey 1993; Shapiro and Seidman 1990; Simon
1976).
In response to an increasing core body temperature, the thermic center, situated in the preoptic
nucleus of the anterior hypothalamus, induces the efferent ﬁbers of the autonomic nervous system to
promote peripheral blood redistribution with skin vasodilatation and sweating.
Volemic depletion, as occurring during dehydration, is a crucial factor in that it impairs heat
dissipation through decreased blood pressure and cardiac output and limited peripheral perfusion
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and sweating, so that intravenous ﬂuids and cooling of the body’s surface are required if the lethal
consequences of hyperthermia are to be avoided (Dill and Costill 1974; Nadel 1981; Strydom and
Holdsworth 1983; Harvey 1993; Shapiro and Seidman 1990; Simon 1976).
In a state of prolonged, severe dehydration, adult body temperature can increase to above
38–40 C for hours or days. Without ﬂuid therapy and cooling, dangerous complications may
occur, including hypotension, tachycardia, arrhythmia, hyperventilation, rhabdomyolysis, dissem-
inated intravascular coagulation, renal tubular necrosis, abnormal liver function, and congestive
heart failure. Typical laboratory ﬁndings are hemoconcentration, proteinuria, ematuria, hypoxia,
early respiratory alkalosis, late lactic acidosis, hypoglycemia, hypokalemia, hypophosphatemia,
hypomagnesemia, and hypocalcemia. The resulting terminal events are shock, myocardial ischemia,
renal failure, serious neurological impairment, and cardiac arrest (Harvey 1993; Shapiro and
Seidman 1990; Simon 1976).
Dehydration therefore causes an abnormal rise in core temperature and low cardiac output with
reduced oxygen delivery to tissues. This in turn leads to progressive decompensation with cardio-
vascular failure, renal failure, lactic acidosis, myocardial ischemia, and central neurological impair-
ment. In these conditions, death often occurs swiftly (Harvey 1993; Shapiro and Seidman 1990;
Simon 1976).
Terminal cardiorespiratory arrest occurs due to severe arrhythmia (atrial ﬂutter, ventricular
tachycardia, ventricular ﬁbrillation) caused by lactic acidosis and dehydration-related electrolyte
depletion (loss of potassium, magnesium, and calcium). Frequent and signiﬁcant postmortem
observations include:
(a) Dry appearance of cutaneous, subcutaneous, and mucosal areas; signiﬁcantly sunken eyes and
dry eyelids; and dry serosal membranes at the peritoneal cavity, pleural cavities, and pericardial
sac.
(b) Atrophy of cardiac muscle reﬂecting a decrease in heart mass; diffuse myocardial areas showing
ﬁber blurring and contraction bands, with micro-necrotic and hemorrhagic lesions.
(c) Macroscopic and histological signs of acute pulmonary edema (diffuse foamy, rose-colored
alveolar ﬂuid, engorged capillaries, thickened alveolar walls, pink intra-alveolar transudates)
(d) Reduction in volume and consistency of both kidneys with histological signs of tubular necrosis
and diffuse vascular congestion.
(e) Atrophy of the medullary regions of the suprarenal glands (Kerndt et al. 1982; Moreschi
et al. 2013).
In order to reconcile the patient’s well-being with his or her advance directives and input from
family members, the decision to withdraw artiﬁcial nutrition and hydration or other treatments must
be, in full observance of ethical and legal rules, the ﬁnal step of a consensus-based decision-making
strategy guided by physicians and involving family, health-care agents, and the clinical team in a
progressive and structured manner (Kerndt et al. 1982; Moreschi et al. 2013).
The aim should be to reach consensus on diagnosis and prognosis (on the basis of existing data
and clinical experience) and to understand the beneﬁts and drawbacks of the various treatments
available while acting within the law and responding to the patient’s wishes and instructions.
Surrogates should also be assured that everything possible will be done to relieve suffering and
maximize dignity and quality of life during the terminal phase (Faber-Langendoen and Lanken
2000).
When the decision is taken to suspend artiﬁcial nutrition and hydration or other treatments which
are proving to be of no beneﬁt to the patient, the priority of the medical and nursing team will be to
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adopt an approach that recognizes the inevitability of death and focuses on the comfort of patients
and their families. All the medical team’s efforts must be oriented to meeting the physical,
emotional, and spiritual needs of dying patients and their families. The ultimate challenge for
clinicians assisting a terminally ill patient is to guarantee dignity and comfort and to ensure quality
of dying and the prevention of any kind of discomfort, by administrating appropriate and adequate
palliative pain control and/or sedation (Faber-Langendoen and Lanken 2000).
Guidelines and Protocols
Notwithstanding the very extensive literature on the ethical and medicolegal reasoning behind
whether to withdraw life-sustaining supports, too little has been done in terms of research, quality
improvement studies, and the training of ICU staff on how to withdraw such supports (Rubenfeld
2004; Siegel 2009; Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen and Lanken 2000).
This lack of standard protocols involving the practical aspects of withdrawing treatment
(medication, artiﬁcial nutrition and hydration, mechanical ventilation and cardiocirculatory support,
and dialysis) may sometimes give rise to the unsatisfactory management of end-of-life care for
critically ill patients (Rubenfeld 2004; Siegel 2009; Truog et al. 2008; Puntillo et al. 2014; Faber-
Langendoen and Lanken 2000).
This may sometimes result in an overly cautious and gradual approach to the withdrawal of life
support or a poor choice of drugs and/or their titration.
Such a slow and gradual approach is not ethically or legally necessary andmay expose the patients
to excessive pain and discomfort, without providing any real beneﬁt (Faber-Langendoen and
Lanken 2000).
On the other hand, when the aim of intensive care treatment shifts to ensuring the patient’s
comfort during the dying process, a progressive and purposeful withdrawal of life-sustaining
supports allied to the right dosage of palliative drugs may be justiﬁed, even if it hastens death
(Rubenfeld 2004; Siegel 2009; Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen and
Lanken 2000).
The development of quality improvement processes involving end-of-care procedures in ICU
settings might promote the implementation of improved and updated protocols, the identiﬁcation of
better decision-making routes, and a withdrawal of life-sustaining supports which offers the greatest
possible comfort to the patient (Rubenfeld 2004; Siegel 2009; Truog et al. 2008; Puntillo et al. 2014;
Faber-Langendoen and Lanken 2000).
ICUs and clinicians should adopt protocols which enable them to:
(a) Evaluate the severity of clinical conditions (using severity of illness scores) and the prognosis
and discuss objectives and treatment options.
(b) Ensure that in the implementation of any kind of triage, through the assessment of available
resources in the ICU, strictly objective criteria are used to assign priority to one patient over
another, while fully recognizing that triage does not condone abandonment of the patient.
(c) Verify the existence of a current advance directive or attempt to reconstruct the patient’s
principles and intentions.
(d) Avoid therapeutic obstinacy if there is no advance directive or if there are no family members or
appointed agents.
(e) Interact appropriately with the patient, agent, family, and friends from a humane and professional
point of view.
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(f) Obtain informed consent without forcing or rushing the patient, family, or agent into decisions.
(g) Identify and stop any treatment which is no longer effective, which is not desired by the patient,
and which does not provide comfort.
(h) Form a plan for carrying out the withdrawal procedure (clearly identifying which treatments
must be continued, withdrawn, or withheld and preparing do-not-resuscitate orders) and for
handling complications.
(i) Move the patient to an appropriate setting and remove any electronic monitoring equipment,
together with catheters, tubes, lines, and drains or any other devices which are no longer
necessary and do not contribute to the patient’s comfort.
(j) Use observational scores to evaluate the patient’s pain and discomfort (a patient under tracheal
intubation or with cognitive impairment due to pharmacological sedation, delirium, or dementia
cannot report his or her symptoms) in order to minimize or eliminate the iatrogenic causes of
physical or psychological pain.
(k) Prescribe the correct dosage and titration of opioids, sedatives, or other drugs to ensure the
control of pain, dyspnea, respiratory distress, delirium, and agitated delirium.
(l) Ensure that the patient, family, and friends receive appropriate psychological, emotional, and
pastoral support.
(m) Document all ethical, legal, clinical, and technical steps in the medical records.
(n) Evaluate the outcome of the withdrawal procedures adopted in order to improve end-of-care ICU
procedures in the future.
(o) Extend psychological and organizational support to clinicians and ICU staff (Rubenfeld 2004;
Siegel 2009; Truog et al. 2008; Puntillo et al. 2014; Faber-Langendoen and Lanken 2000; Barr
et al. 2013; Moreschi et al. 2013) (Table 6).
Furthermore, if we accept that the withdrawal of life-sustaining treatments in ICU settings is in
fact a medical procedure, we need to design and divulgate standard procedures and protocols aimed
Table 6 The progressive steps in the withdrawal of life support
Evaluate the severity of clinical conditions (using severity of illness scores) and the prognosis and discuss objectives and
treatment options
Ensure that any kind of triage in the ICU, assigning priority to one patient over another, does not result in abandonment
of the patient
Verify the existence of a current advance directive or attempt to reconstruct the patient’s principles and intentions
Avoid therapeutic obstinacy if there is no advance directive or if there are no family members or appointed agents
Interact appropriately with the patient, agent, family, and friends from a humane and professional point of view
Obtain informed consent without forcing or rushing the patient, family, or agent into decisions
Identify and stop any treatment which is no longer effective, which is not desired by the patient, and which does not
provide comfort
Form a plan for carrying out the withdrawal procedure, identifying which treatments must be continued, withdrawn, or
withheld, and preparing do-not resuscitate orders and instructions for handling complications
Move the patient to an appropriate setting, and remove any electronic monitoring equipment, together with catheters,
tubes, lines, and drains or any other devices which are no longer necessary and do not contribute to the patient’s comfort
Use observational scores to evaluate the patient’s pain and discomfort in order to minimize or eliminate the iatrogenic
causes of physical or psychological pain
Prescribe the correct dosage and titration of opioids, sedatives, or other drugs to ensure the control of pain, dyspnea,
respiratory distress, delirium, and agitated delirium
Ensure that the patient, family, and friends receive appropriate psychological, emotional, and pastoral support
Document all ethical, legal, clinical, and technical steps in the medical records
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at improving the end-of-life care of dying patients (Rubenfeld 2004; Siegel 2009; Truog et al. 2008;
Puntillo et al. 2014; Faber-Langendoen and Lanken 2000; Barr et al. 2013; Moreschi et al. 2013).
Summary Points
• The withdrawal of artiﬁcial nutrition and hydration together with other life-sustaining supports in
ICUs or other settings is a clinical response to cases of terminal adult patients suffering from
irreversible diseases or who are in a state of impaired consciousness with no hope of improvement
or recovery.
• Such clinical procedures should be pursued in the best interests of the dying patient and with the
aim of avoiding therapeutic obstinacy, limiting suffering, and safeguarding the patient’s dignity.
• The decision to withdraw artiﬁcial nutrition and hydration or other life-sustaining supports, in
compliance with the ethical codes and legal systems in individual countries, should be the ﬁnal
step in a structured, professional, interactive process involving physicians, health-care teams,
patients, and families or appointed agents.
• The management of the death process, including the withdrawal of artiﬁcial sustenance or life-
sustaining treatments, is a medical procedure and does not equate to euthanasia; it demands
speciﬁc professional skills from intensivists and ICU staff who are required to operate using
standard procedures and protocols in order to improve the end-of-life care of dying patients.
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